As pharma’s customer landscape becomes more complex, our perception of value has changed. Just you wouldn’t be caught dead wearing those flares that were once your most prized possession, it’s no longer enough to focus only on the medicine.
What worked ten years ago does simply not feel right anymore and, increasingly, our customers require more comprehensive solutions.
So what are the disease-specific, technically-specific or customer-specific competencies that will create a new set of assets? How will the medicines we develop require new ways of operating and interacting with our customer?
During the hour, we’ll be looking at how companies are building new competencies and assets in non-drug areas, whether we can rely on our collective pipelines for our long-term prosperity, what new partnerships and competencies need to be built for improved personalisation in our medicines, and whether the international community is able and willing to reward pharma for this type of innovation.
We will leave the session having a better idea of where we should be placing our resources and energy over the next few years.
Please join us at https://goo.gl/toq9S8 .
And don’t worry if you’re busy on October 3rd – by registering, you’ll receive a recording of the session!